Question: What treatments are available for people with moderate to severe asthma for COVID-19

Answer passage (source: CDC):
page_title: People with Moderate to Severe Asthma
section_headers: Risk of Severe Illness from COVID-19
section_content: People with moderate to severe asthma may be at higher risk of getting very
sick from COVID-19. COVID-19 can affect your respiratory tract (nose, throat,
lungs), cause an asthma attack, and possibly lead to pneumonia and acute
respiratory disease.

Reviewer feedback on this answer:
The answer does not address what treatments are available for people with asthma.
This answer addresses asthma, but not asthma treatments.

Reviewer ratings:
Bad
Could be Improved

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Asthma
If my patient experiences an asthma exacerbation, should the exacerbation be treated any differently to reduce risk of COVID-19?
section_content: Selection of therapeutic options through guideline-recommended treatment of
asthma exacerbations has not been affected by what we currently know about
COVID-19.
Systemic corticosteroids should be used to treat an asthma exacerbation per
national asthma guidelinesexternal icon and current standards of
care, even if it is caused by COVID-19. Short-term use of systemic
corticosteroids to treat asthma exacerbations should be continued. There is
currently no evidence to suggest that short-term use of systemic
corticosteroids to treat asthma exacerbations increases the risk of developing
severe COVID-19, whereas there is an abundance of data to support use of
systemic steroids for moderate or severe asthma exacerbations.
Patients with asthma but without symptoms or a diagnosis of COVID-19 should
continue any required nebulizer for treatments, as recommended by national
professional organizations, including the American Academy of Allergy, Asthma
& Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology
(ACAAI). If healthcare providers need to be present during nebulizer use among
patients who have either symptoms or a diagnosis of COVID-19, use CDC’s
recommended precautions when performing aerosol-generating procedures
(AGPs).
Clinicians may be concerned that an asthma exacerbation is related to an
underlying infection with COVID-19. Clinicians can access laboratory testing
for COVID-19 through a network of state and local public health laboratories
across the country. Lists of states and territories with
laboratories that are
using COVID-19 viral tests are available. For more information, see Testing
in U.S. Clinicians
should direct testing questions to their
state
and localexternal icon
health departments.

Reviewer feedback on this answer:
This answer relates to the question and is thorough.
Treatments used to help asthma patients are discussed thoroughly.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: CDC):
page_title: People with Moderate to Severe Asthma
section_headers: Treatment
section_content: There is currently no specific treatment for or vaccine to prevent COVID-19.
The best way to prevent illness is to avoid being exposed to this virus.

Reviewer feedback on this answer:
This answer has nothing to do with asthma.
This answer is too vague, and applies to everyone, not just those with asthma.

Reviewer ratings:
Bad
Bad